Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Lifevantage Corporation (LXRX)

« Back to company index

LXRX Chatter Timeline

Stock Ticker for LXRX

Most Active Tweeters for LXRX

UserTweets
@AmericanBanking 4
@ConsumerFeed 1
@SleekMoneycom 1
@RTradesCapital 1
@ez_alertz 1

Recent Tweets for LXRX

ez_alertz @ez_alertz
$LXRX AstraZeneca's Farxiga Gets CRL from FDA for Type I Diabetes https://t.co/XYbBzyJWw9
July 15th 2019, 6:07pm
AmericanBanking @AmericanBanking
Brokerages Anticipate Lexicon Pharmaceuticals, Inc. $LXRX Will Announce Quarterly Sales of $24.66 Million https://t.co/3MqbQc8ggb #stocks
July 15th 2019, 2:07am
AmericanBanking @AmericanBanking
Lexicon Pharmaceuticals, Inc. $LXRX Sees Large Growth in Short Interest https://t.co/G5mw9NNmSi #stocks
July 14th 2019, 12:07pm
AmericanBanking @AmericanBanking
-$0.09 Earnings Per Share Expected for Lexicon Pharmaceuticals, Inc. $LXRX This Quarter https://t.co/acAkQPyVII #stocks
July 13th 2019, 6:07pm
ConsumerFeed @ConsumerFeed
Lexicon Pharmaceuticals $LXRX Stock Price Passes Above 50 Day Moving Average of $5.89 https://t.co/PzMWkyqMKW
July 12th 2019, 1:07pm
AmericanBanking @AmericanBanking
Lexicon Pharmaceuticals, Inc. $LXRX Given Average Recommendation of “Hold” by Analysts https://t.co/YoVZGNvrxB #stocks
July 12th 2019, 4:07am
TheMarketsDaily @TheMarketsDaily
Zacks Investment Research Lowers Lexicon Pharmaceuticals $LXRX to Hold https://t.co/n9kgBp6TTJ
July 7th 2019, 5:07am
storminvestor @storminvestor
Zacks Investment Research Lowers Lexicon Pharmaceuticals $LXRX to Hold https://t.co/qiKhJciC8c #markets
July 7th 2019, 5:07am
macondailynews @macondailynews
Zacks Investment Research Lowers Lexicon Pharmaceuticals $LXRX to Hold https://t.co/ZizLBHFtcZ
July 7th 2019, 5:07am
stocknewstimes @stocknewstimes
Zacks Investment Research Lowers Lexicon Pharmaceuticals $LXRX to Hold https://t.co/X47lML5ibl
July 7th 2019, 5:07am
SleekMoneycom @SleekMoneycom
Zacks Investment Research Lowers Lexicon Pharmaceuticals $LXRX to Hold https://t.co/ZFpmjHpdeo #investing
July 7th 2019, 5:07am
ZolmaxNews @ZolmaxNews
Lexicon Pharmaceuticals $LXRX Rating Lowered to Hold at Zacks Investment Research https://t.co/i8GV9gUC8X
July 5th 2019, 2:07am
TickerReport @TickerReport
Lexicon Pharmaceuticals $LXRX Cut to “Hold” at Zacks Investment Research https://t.co/i31fGTryO8
July 5th 2019, 2:07am
BeefEnt @BeefEnt
Lexicon Pharmaceuticals Inc NASDAQ: $LXRX Health Care : Biotechnology | Small Cap Growth Company profile BuySell Closing Price $6.36
July 4th 2019, 10:07am
Gambiste1 @Gambiste1
RT @RTradesCapital: $LXRX low float stock. Ready for some PRs.
July 3rd 2019, 4:07pm
Tickeron @Tickeron
A.I.dvisor made a bullish call on $LXRX, netting in a 17.88% gain over 2 weeks https://t.co/SZEJnD1cqK https://t.co/xzHGU5OmIM
July 3rd 2019, 2:07pm
RTradesCapital @RTradesCapital
$LXRX low float stock. Ready for some PRs.
July 3rd 2019, 10:07am
ResearchPool @ResearchPool
$LXRX #Lexicon Pharmaceuticals Inc Maintaining Our Lexicon FVE Following Zynquistas Europe Approval and Modest 1Q X… https://t.co/srgVuREsU4
July 1st 2019, 7:07pm
ConsumerFeed @ConsumerFeed
Lexicon Pharmaceuticals $LXRX Downgraded by BidaskClub to “Sell” https://t.co/s1goyz3dro
July 1st 2019, 3:07am
IRAMarketReport @IRAMarketReport
Lexicon Pharmaceuticals $LXRX Downgraded by BidaskClub to “Sell” https://t.co/9zYNSDFF3w #markets
July 1st 2019, 3:07am
chaffeybreeze @chaffeybreeze
Lexicon Pharmaceuticals $LXRX Downgraded by BidaskClub to “Sell” https://t.co/zRdXyo85n2 #stocks
July 1st 2019, 3:07am
ThisLincolnian @ThisLincolnian
Lexicon Pharmaceuticals $LXRX Cut to Sell at BidaskClub https://t.co/WW0jTG5l5w
June 30th 2019, 8:06am
bbnsnews @bbnsnews
Lexicon Pharmaceuticals $LXRX Cut to Sell at BidaskClub https://t.co/Xystsr9wUZ
June 30th 2019, 8:06am
TickerReport @TickerReport
Lexicon Pharmaceuticals $LXRX Downgraded by BidaskClub https://t.co/y7R5lFFFY1
June 28th 2019, 10:06am
OlympiaReport @OlympiaReport
Lexicon Pharmaceuticals, Inc. $LXRX Expected to Announce Earnings of -$0.09 Per Share https://t.co/fk9asrPv9b
June 27th 2019, 4:06pm
dispatchtribune @dispatchtribune
-$0.09 Earnings Per Share Expected for Lexicon Pharmaceuticals, Inc. $LXRX This Quarter https://t.co/U3v7Eqt6FG
June 27th 2019, 4:06pm
registrarjourn @registrarjourn
Lexicon Pharmaceuticals, Inc. $LXRX Expected to Announce Earnings of -$0.09 Per Share https://t.co/gXC4k31uBf
June 27th 2019, 4:06pm
EnterpriseLeade @EnterpriseLeade
Lexicon Pharmaceuticals, Inc. $LXRX Expected to Announce Earnings of -$0.09 Per Share https://t.co/4Uns2uPg4G
June 27th 2019, 4:06pm
ThisLincolnian @ThisLincolnian
Analysts Anticipate Lexicon Pharmaceuticals, Inc. $LXRX Will Announce Quarterly Sales of $24.66 Million https://t.co/SxAOuUMQTi
June 27th 2019, 4:06pm
WeekHerald @WeekHerald
Analysts Anticipate Lexicon Pharmaceuticals, Inc. $LXRX Will Post Quarterly Sales of $24.66 Million https://t.co/iSJD322Qej
June 27th 2019, 4:06pm
ProVesting @ProVesting
$LXRX $CMRE: Here is What Hedge Funds Think About Lexicon Pharmaceuticals …: https://t.co/sLj8OY8i8N
June 26th 2019, 2:06pm
tradnews_ @tradnews_
RT @TrendSpider: $LXRX when in doubt, create bi-directional price alerts, and go relax :) https://t.co/GQBo2wWbmS
June 26th 2019, 12:06am
TrendSpider @TrendSpider
$LXRX when in doubt, create bi-directional price alerts, and go relax :) https://t.co/GQBo2wWbmS
June 25th 2019, 11:06pm
TickerReport @TickerReport
Zacks: Brokerages Expect Lexicon Pharmaceuticals, Inc. $LXRX to Post -$0.09 EPS https://t.co/KOF97hCpgv
June 25th 2019, 9:06am
TheMarketsDaily @TheMarketsDaily
BidaskClub Upgrades Lexicon Pharmaceuticals $LXRX to “Hold” https://t.co/iXg9NLiuMC
June 24th 2019, 2:06am
macondailynews @macondailynews
BidaskClub Upgrades Lexicon Pharmaceuticals $LXRX to “Hold” https://t.co/Ui37Vb0Hx3
June 24th 2019, 2:06am
OlympiaReport @OlympiaReport
Lexicon Pharmaceuticals $LXRX Upgraded at BidaskClub https://t.co/hOkJWwz8Dn
June 23rd 2019, 8:06am
ThisLincolnian @ThisLincolnian
Lexicon Pharmaceuticals $LXRX Upgraded at BidaskClub https://t.co/mt0WMvEyqd
June 23rd 2019, 8:06am
WeekHerald @WeekHerald
BidaskClub Upgrades Lexicon Pharmaceuticals $LXRX to “Hold” https://t.co/EdKFjjdGVU
June 23rd 2019, 8:06am
TickerReport @TickerReport
Brokerages Set Lexicon Pharmaceuticals, Inc. $LXRX Target Price at $16.38 https://t.co/BPaRhLmj7W
June 22nd 2019, 3:06pm
dakotafinancial @dakotafinancial
Brokerages Set Lexicon Pharmaceuticals, Inc. $LXRX Target Price at $16.38 https://t.co/2Y24UGnCbj
June 22nd 2019, 3:06pm
AmericanBanking @AmericanBanking
Lexicon Pharmaceuticals, Inc. $LXRX Expected to Post Quarterly Sales of $24.66 Million https://t.co/SwOa77cBNA #stocks
June 22nd 2019, 2:06am
TickerReport @TickerReport
Lexicon Pharmaceuticals $LXRX Upgraded by BidaskClub to “Hold” https://t.co/DBEV8B4BNw
June 21st 2019, 9:06am
SwingTradeBot @SwingTradeBot
Fell Below 50 DMA today: $LXRX ... https://t.co/j2lcQOTpfA
June 20th 2019, 4:06pm
AmericanBanking @AmericanBanking
Analysts Expect Lexicon Pharmaceuticals, Inc. $LXRX Will Post Earnings of -$0.09 Per Share https://t.co/6vBu9medX8 #stocks
June 20th 2019, 2:06pm
AmericanBanking @AmericanBanking
Short Interest in Lexicon Pharmaceuticals, Inc. $LXRX Drops By 20.5% https://t.co/OdFymTysq8 #stocks
June 17th 2019, 12:06pm
AmericanBanking @AmericanBanking
Lexicon Pharmaceuticals, Inc. $LXRX Receives Average Rating of “Hold” from Analysts https://t.co/AHpMYRy3gM #stocks
June 17th 2019, 4:06am
WeekHerald @WeekHerald
Lexicon Pharmaceuticals, Inc. $LXRX Receives Consensus Rating of “Hold” from Analysts https://t.co/QOFEvKLPCQ
June 17th 2019, 4:06am
midetimes @midetimes
Lexicon Pharmaceuticals $LXRX Given a $35.00 Price Target at Wedbush https://t.co/wQuyfnDCj2 #stocks
June 15th 2019, 3:06am
dailymailtimes @dailymailtimes
Lexicon Pharmaceuticals $LXRX Given a $35.00 Price Target at Wedbush https://t.co/pHO3bVp4aR #investing
June 15th 2019, 3:06am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.